Geneva — The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns, WHO director-general Tedros Adhanom Ghebreyesus said on Monday.
Hydroxycholoroquine has been touted by US President Donald Trump and Brazil's Jair Bolsonaro, among others, as a possible treatment for the disease caused by the novel coronavirus. Trump is taking the drug in a bid to help prevent infection...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.